Neuro-immune interactions in paclitaxel-induced peripheral neuropathy

Volume: 60, Issue: 10, Pages: 1369 - 1382
Published: Jul 27, 2021
Abstract
Paclitaxel is a taxane-based chemotherapeutic agent used as a treatment in breast cancer. There is no effective prevention or treatment strategy for the most common side effect of peripheral neuropathy. In this manuscript, we reviewed the molecular mechanisms that contribute to paclitaxel-induced peripheral neuropathy (PIPN) with an emphasis on immune-related processes.A systematic search of the literature was conducted in PubMed, EMBASE and...
Paper Details
Title
Neuro-immune interactions in paclitaxel-induced peripheral neuropathy
Published Date
Jul 27, 2021
Volume
60
Issue
10
Pages
1369 - 1382
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.